Specialist advisory firm focused on commercial real estate investment, asset management and capital markets solutions for institutional and private clients. City Center Advisors, LLC provides deal origination, portfolio strategy, disposition execution and debt/equity placement, typically on mid-market urban office, retail and mixed-use assets. Market-facing capabilities emphasize structured financing, investor relations and transaction advisory to support value-add and opportunistic allocations across regional U.S. markets.
Specialist advisory firm focused on commercial real estate investment, asset management and capital markets solutions for institutional and private clients. City Center Advisors, LLC provides deal origination, portfolio strategy, disposition execution and debt/equity placement, typically on mid-market urban office, retail and mixed-use assets. Market-facing capabilities emphasize structured financing, investor relations and transaction advisory to support value-add and opportunistic allocations across regional U.S. markets.
Focuses on deploying capital into mid-market urban commercial real estate through a disciplined, market-driven approach that blends value-add acquisitions, structured finance and active asset management. Emphasizes sourcing proprietary deal flow, underwriting downside with conservative leverage, and executing tailored disposition and recapitalization strategies to unlock NOI growth. Sector focus prioritizes office, retail and mixed-use in regional U.S. markets with a hold-to-exit horizon oriented around 3–7 year value realization and investor-aligned risk-return profiles.
Focuses on deploying capital into mid-market urban commercial real estate through a disciplined, market-driven approach that blends value-add acquisitions, structured finance and active asset management. Emphasizes sourcing proprietary deal flow, underwriting downside with conservative leverage, and executing tailored disposition and recapitalization strategies to unlock NOI growth. Sector focus prioritizes office, retail and mixed-use in regional U.S. markets with a hold-to-exit horizon oriented around 3–7 year value realization and investor-aligned risk-return profiles.
| Trades 1588 | Longs Won 1009/1588 63% | Profit Factor 3.49 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $107,908.19 |
| Average Win $34,467.46 | Best Trade (Oct 15) $3.63M | Sharpe Ratio -10.16 |
| Average Loss -$17,230.34 | Worst Trade (Mar 30) -$258,231.51 | Z-Score -0.77 (56.09%) |
| Commissions $0 | Avg. Trade Length 9m 4w | Expectancy $15,617.95 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 7,634 | 6,870 | 6,107 | 5,344 | 4,580 | 3,817 | 3,053 | 2,290 | 1,527 | 763 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 7,551 | $1.69M | $2.59M | - | $899,752.93 | 53.24% | +0.495% |
ADI Analog Devices, Inc. | 1,663 | $562,101.41 | $689,646.12 | - | $127,544.71 | 22.69% | 0.0 |
ADM Archer-Daniels-Midland Co | 3,983 | $305,707.41 | $331,385.6 | - | $25,678.19 | 8.4% | 0.0 |
ADMA Adma Biologics Inc. | 37,628 | $377,409 | $389,073.52 | - | $11,664.52 | 3.09% | +0.291% |
AFK VanEck Vectors Africa Index ETF | 8,655 | $231,058.98 | $231,175.05 | - | $116.07 | 0.05% | 0.0 |
AGG iShares Core U.S. Aggregate Bond ETF | 13,048 | $1.29M | $1.24M | - | -$52,682.2 | -4.09% | 0.0 |
AMD Advanced Micro Devices, Inc. | 1,451 | $295,176.78 | $878,624.07 | - | $583,447.29 | 197.66% | 0.0 |
AMGN Amgen Inc. | 619 | $181,822.15 | $255,547.96 | - | $73,725.81 | 40.55% | 0.0 |
AVGO Broadcom Inc. | 4,040 | $880,694.18 | $1.4M | - | $518,155.82 | 58.83% | -3.095% |
AXP American Express Company | 878 | $288,479.48 | $272,039.52 | - | -$16,439.96 | -5.7% | 0.0 |
BAC Bank of America Corporation | 4,007 | $228,157.55 | $216,217.72 | - | -$11,939.83 | -5.23% | 0.0 |
BALT Inn Defined Wealth Shield Mutual Fund | 12,872 | $432,077.75 | $451,163.59 | - | $19,085.84 | 4.42% | 0.0 |
BAPR Innovator U.S. Equity Buffer ETF | 16,208 | $693,697.62 | $892,574.56 | - | $198,876.94 | 28.67% | 0.0 |
BEN Franklin Resources Inc. | 6,605 | $219,748.55 | $205,943.9 | - | -$13,804.65 | -6.28% | 0.0 |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 5,283 | $484,619.54 | $483,500.16 | - | -$1,119.38 | -0.23% | 0.0 |
BJAN Innovator U.S. Equity Buffer ETF - January | 14,776 | $691,009.37 | $905,857.46 | - | $214,848.09 | 31.09% | 0.0 |
BJUL Innovator U.S. Equity Buffer ETF | 16,112 | $699,981.9 | $905,333.28 | - | $205,351.38 | 29.34% | 0.0 |
BNDX Vanguard Total International Bond ETF | 16,001 | $779,617.74 | $752,206.98 | - | -$27,410.76 | -3.52% | 0.0 |
BOCT Innovator U.S. Equity Buffer ETF BOCT | 16,362 | $706,967.53 | $906,732.95 | - | $199,765.42 | 28.26% | -0.811% |
BRK-B Berkshire Hathaway Inc. | 685 | $340,274.87 | $356,706.9 | - | $16,432.03 | 4.83% | +0.029% |